Comparative efficacy and safety of mycophenolate mofetil vs cyclophosphamide for induction therapy in childhood-onset lupus nephritis: Updated meta-analysis
World Journal of Clinical Pediatrics · 05.11.2026
DOI: 10.5409/wjcp.127054 ↗Kurz gefasst
Metaanalyse in der Zeitschrift World Journal of Clinical Pediatrics, online erschienen am 05.11.2026. Verfasst von Muhammad Husnain Mumtaz und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mumtaz, M. H., Arif, A., Sawan, E. S., Nawal, A., Kotak, P., Hassan, A., Joy, B., Amir, A., Lescaie, A., Amin, F., Sheikh, M. I., Shahid, H., Nadeem, I., Alkashlan, E., & Saad, K. (2026). Comparative efficacy and safety of mycophenolate mofetil vs cyclophosphamide for induction therapy in childhood-onset lupus nephritis: Updated meta-analysis. World Journal of Clinical Pediatrics. https://doi.org/10.5409/wjcp.127054
Vancouver
Mumtaz MH, Arif A, Sawan ES, Nawal A, Kotak P, Hassan A, et al. Comparative efficacy and safety of mycophenolate mofetil vs cyclophosphamide for induction therapy in childhood-onset lupus nephritis: Updated meta-analysis. World Journal of Clinical Pediatrics. 2026. doi:10.5409/wjcp.127054
BibTeX
@article{Mumtaz2026,
author = {Mumtaz, Muhammad Husnain and Arif, Aliza and Sawan, Eman S and Nawal, Ayesha and Kotak, Pari and Hassan, Ali and Joy, Basil and Amir, Aiman and Lescaie, Andreea and Amin, Fahad and Sheikh, Maryam Imran and Shahid, Humna and Nadeem, Iqra and Alkashlan, Ebrahim and Saad, Khaled},
title = {Comparative efficacy and safety of mycophenolate mofetil vs cyclophosphamide for induction therapy in childhood-onset lupus nephritis: Updated meta-analysis},
journal = {World Journal of Clinical Pediatrics},
year = {2026},
doi = {10.5409/wjcp.127054}
}
EUVIMED